DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» CID16020046
CID16020046
Cannabidiol Attenuates Seizures and Social Deficits in a Mouse Model of Dravet Syndrome
Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer
P.1.G.070 PHARMACOLOGICAL BLOCKADE of GPR55 in the ANTERIOR CINGULATE CORTEX REDUCES FORMALIN-EVOKED NOCICEPTIVE BEHAVIOUR in RATS Bright N
Icrs2015 Programme
A Selective Antagonist Reveals a Potential Role of G Protein-Coupled
Anti-Melanoma Activity of AM251
THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner
The Gastrointestinal Tract – a Central Organ of Cannabinoid Signaling in Health and Disease
Cannabinoids for Treating Inflammatory Bowel Diseases: Where Are We and Where Do We Go?
Possible Role of Hippocampal GPR55 in Spatial Learning and Memory in Rats
Identification and Pharmacological Evaluation of Surrogate Ligands of Cannabinoid Receptors
The Therapeutic Potential of Cannabis in Counteracting Oxidative Stress and Inflammation
( 12 ) United States Patent ( 10 ) Patent No .: US 10,960,035 B2 Koltai Et Al
Peptide Targeting of Lysophosphatidylinositol-Sensing GPR55 for Osteoclastogenesis Tuning
O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity In
GPR55 Receptor Activation by the N-Acyl Dopamine Family Lipids Induces Apoptosis in Cancer Cells Via the Nitric Oxide Synthase (Nnos) Over-Stimulation
International Cannabinoid Research Society
ICRS2017 Symposium Final Programme
Top View
Anandamide, Acting Via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures
The Novel Cannabinoid Receptor GPR55 Mediates Anxiolytic-Like Effects in the Medial Orbital Cortex of Mice with Acute Stress
An Examination of the Impact of Habitual Cannabis Use on Vascular Health, Cardiac Function, and Cardiac Structure in Healthy Adults
Molecular Mechanism of Cannabinoids in Cancer Progression
TRPV1 Mediates Cellular Uptake of Anandamide and Thus Promotes Endothelial Cell Proliferation and Network-Formation
GPR119 and GPR55 As Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
A Guide to Targeting the Endocannabinoid System in Drug Design
Cannabinoid Pharmacology and Therapy in Gut Disorders. Uranga Et Al 2018
CANNABINOID 2 RECEPTOR and GPR55 AS THERAPEUTIC TARGETS in EXPERIMENTAL SEPSIS by Olivia Hyewon Yang Submitted in Partial Fulfil
The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
GPR55: a New Promising Target for Metabolism?
Preclinical Validation of Endocannabinoid System Drug Targets for the Treatment of Dravet Syndrome
Cannabinoid Signaling
PANCAN-2018-0019-Ver9-Sharafi 2P 1..7
The Endocannabinoid System and Its Putative Receptors GPR18 and GPR55
O-1602 Promotes Hepatic Steatosis Through GPR55 and PI3 Kinase/Akt/SREBP-1C Signaling in Mice
Biological Activity of Cannabis Sativa L. Extracts Critically Depends on Solvent Polarity and Decarboxylation
Possible Role of Hippocampal GPR55 in Spatial Learning and Memory in Rats
LINGERFELT, MARY A., Ph.D. Construction and Validation of GPR55 Active and Inactive State in Silico Models Through the Use of Bi
The GPR 55 Agonist, L-Α- Lysophosphatidylinositol, Mediates Ovarian Carcinoma Cell-Induced Angiogenesis
Cannabinoids in the Landscape of Cancer
Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease